These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2929589)

  • 1. Reversible agranulocytosis related to azidothymidine therapy.
    Goldsmith JC; Irvine W
    Am J Hematol; 1989 Apr; 30(4):263-4. PubMed ID: 2929589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin and neutropenia in AZT-treated AIDS patients with staphylococcal infections.
    Kitchen LW; Clark RA; Hanna BJ; Pollock B; Valainis GT
    J Acquir Immune Defic Syndr (1988); 1990; 3(9):925-6. PubMed ID: 2384869
    [No Abstract]   [Full Text] [Related]  

  • 3. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
    Smiley L
    J Infect; 1989 Jan; 18 Suppl 1():77. PubMed ID: 2644363
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
    Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
    Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    Richman DD; Fischl MA; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D; Hirsch MS
    N Engl J Med; 1987 Jul; 317(4):192-7. PubMed ID: 3299090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
    Fischl M; Galpin JE; Levine JD; Groopman JE; Henry DH; Kennedy P; Miles S; Robbins W; Starrett B; Zalusky R
    N Engl J Med; 1990 May; 322(21):1488-93. PubMed ID: 2186273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.
    Schmitt FA; Bigley JW; McKinnis R; Logue PE; Evans RW; Drucker JL
    N Engl J Med; 1988 Dec; 319(24):1573-8. PubMed ID: 3059187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AZT for children with AIDS.
    Engel NS
    MCN Am J Matern Child Nurs; 1989; 14(2):121. PubMed ID: 2495409
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine.
    Casoli C; Magnani G; Schianchi C; Barchi E; Bertazzoni U
    AIDS; 1990 Aug; 4(8):799-802. PubMed ID: 2261134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
    Whitfield RM; Bechtel LM; Starich GH
    Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azidothymidine.
    Oksenhendler E
    Nouv Rev Fr Hematol (1978); 1989; 31(2):69-72. PubMed ID: 2671931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome.
    Phillips NC; Tsoukas C
    Blood; 1992 Mar; 79(5):1137-43. PubMed ID: 1371411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS).
    Gill PS; Rarick M; Brynes RK; Causey D; Loureiro C; Levine AM
    Ann Intern Med; 1987 Oct; 107(4):502-5. PubMed ID: 3477107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coma during azidothymidine therapy for AIDS.
    Riedel RR; Clarenbach P; Reetz KP
    J Neurol; 1989 Mar; 236(3):185. PubMed ID: 2709071
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum thymidine kinase--a marker of bone marrow toxicity during treatment with zidovudine.
    Pedersen C; Ingeberg S; Teglbjaerg LS
    AIDS; 1989 Nov; 3(11):743-6. PubMed ID: 2515880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marrow suppression hampers AZT use in AIDS victims.
    Kolata G
    Science; 1987 Mar; 235(4795):1463. PubMed ID: 3823897
    [No Abstract]   [Full Text] [Related]  

  • 17. 3'-Azido-3'-deoxythymidine ameliorates the thrombocytopenia observed in a murine model of AIDS.
    Chow FP; Sutton PA; Hamburger AW
    Exp Hematol; 1990 Oct; 18(9):1038-41. PubMed ID: 2168839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS.
    Chow FP; Hamburger AW
    Eur J Haematol; 1991 Aug; 47(2):91-7. PubMed ID: 1889487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime treatment of mice with azidothymidine (AZT) produces myelodysplasia.
    Inoue T; Cronkite EP; Hirabayashi Y; Bullis JE; Mitsui H; Umemura T
    Leukemia; 1997 Apr; 11 Suppl 3():123-7. PubMed ID: 9209318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
    Reddy MM; McKinley G; Englard A; Grieco MH
    J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.